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Identity 
Other names: Catabolin; IL-1; IL-1B; IL1-BETA; 
IL1F2; pro-interleukin-1-beta 
HGNC (Hugo): IL1B 
Location: 2q13 
Note: IL-1beta is a pro-inflamatory cytokine and is 
expressed by many cells including macrophage, NK 
cells, monocytes, and neutrophils. It belongs to the IL-1 
family cluster that includes the IL-1a, and IL1-RN 
genes. The caspase 1 (CASP1/ICE) gene proteolitically 
activates IL-1β. This gene is involved in the 
proliferation, differentiation and apoptosis of cells. 
Inflammatory hypersensitivity has been found to be the 
result of IL-1β activation of cyclooxygenase-2 
(PTGS2/COX2). IL-1beta has also been associated 
with septic shock, and wound healing. 
DNA/RNA 
Note 
IL-1beta is located on Chromosome 2 at location 
113,303,808-113,310,827. It is located in the middle of 
IL-1a and IL1-RN between 40 and 110kb from IL-1a. 
The pro IL-1β gene is composed of seven exons with a 
primary transcription product length of 7,008 
nucleotides. 
Description 
The gene spans a region of 7.5 kb and the coding part is 
divided into seven exons. 
Transcription 
Transcript length: 1,498 bps; Translation length: 269 
residues. 
Protein 
Description 
269 amino acids. 
Function 
IL-1 proteins are considered endogenous pyrogens 
since they are involved in inflammatory responses and 
also have been observed to foment prostaglandin and 
collagenase release from synovial cells. Additionally, 
IL-1 is responsible for the induction of IL-2 release, B-
cell maturation/proliferation, and fibroblast growth 
factor activity, that stimulates thymocyte proliferation. 
Homology 
IL-1beta shares sequence homology with IL-1a and 
IL1-RN. IL-1beta and IL-1a have an amino acid 
homology between them of approximately 25%. 
Implicated in 
Gastric cancer 
Note 
Interleukin-1 beta overexpression is associated with the 
increased risk of both hypochlorhydria induced by H. 
pylori and gastric cancer (El-Omar et al., 2000). 
Enhancement of IL-1beta production was determined to 
be caused by polymorphisms in the interleukin-1 gene 
cluster. The pro-inflammatory properties of the IL-1 
beta cytokine could explain the association with gastric 
cancer, also considering it is an important inhibitor of 
acid secretion. 
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Growth of estrogen-dependent tumors 
Oncogenesis 
In the pathogenesis of estrogen-dependent cancers, 
particularly, breast and ovary, the role of IL-1β is 
implicated in protumorigenic insults, cell proliferation, 
angiogenesis and cell adhesion. It appears that it is the 
concentration of the peptide interleukin-1 beta which 
determines its stimulatory or inhibitory paracrine 
and/or autocrine signals that regulate the growth of 
estrogen-dependent tumors. The IL-1β over expressing 
stable MCF7 cell secreting high level of IL-1β peptides 
shows inhibition of cell growth compared to 
nontransfected cells, and elevated level of p53 protein 
is detected in these cells (Roy et al., 2006). Stably IL-
1beta transfected cells secreting moderate level of IL-
1β peptides stimulate the clonal expansion of MCF7 
cells. Different cellular signaling may operate in 
response to varying levels of IL-1β leading to 
genotoxic damage, cell apoptosis or cell growth . 
Tumorigenesis 
Oncogenesis 
Il-1 beta has also been found to stimulate the local 
production of chemotactic factors for 
polymorphonuclear leukocytes (PMN's) in tumors; 
PMN's may play an important role in the inhibition of 
tumor growth. 
On the other hand, other studies have found IL-1 beta 
to promote tumor growth. According to Vidal-
Vanaclocha et al. (2000), IL-1 beta along with tumor 
necrosis factor-alpha (TNF-alpha), up-regulate the 
expression of vascular cell adhesion molecule-1 
(VCAM-1) on hepatic sinusoidal endothelium (HSE) in 
vivo which promotes cancer cell adhesion and liver 
metastases. 
Cardiovascular risk, cardiovascular 
diseases 
Note 
Increased Cardiovascular Risk, Cardiovascular 
Diseases 
Prognosis 
SNPs in the interleukin-1beta gene has been reported to 
be associated with lower expression of basal CRP, a 
heritable acute-phase plasma protein, in healthy 
individuals. Elevated basal CRP has been associated 
with increased cardiovascular risk.  
Additionally, an inflammatory cascade involving TNF, 
IL-1 beta and IL-6 has been suggested to play an 
important role in the pathogenesis of common 
postoperative problems associated with cardiac surgery 
involving a cardiopulmonary bypass. Increased levels 
of IL-6 release were associated with higher serum 
levels of TNF-a and IL-1β after surgery, in patients 
undergoing coronary artery bypass grafting (CABG) 
with cardiopulmonary bypass (CPB). 
Liver surgery 
Note 
Changes in tumor necrosis factor-a and interleukin-1 
beta production following liver surgery. 
Oncogenesis 
For cirrhotic patients undergoing liver surgery, changes 
of IL-1B and tumor necrosis factor-a levels are 
observed, suggesting that these two genes play an 
important role in the pathogenesis of postoperative 
liver failures. Important tissue injury and/or endotoxin, 
organ failures could develop and progress after 
stimulation of cytokine production in monocytes by 
factors such as insufficient blood supply (ischemia). 
Inflammation 
Prognosis 
IL-1 beta gene might be an important neuroregulator of 
responses to inflammatory stressors in the central 
nervous system considering that overexpression of the 
IL-1 beta gene has been found in the CNS during 
systemic inflammation. IL-1a and IL-1b induction in 
the hypothalamus may regulate neuroendocrine 
functions during infection and inflammation. Wong et 
al (1997) propose that actions of brain IL-1 beta during 
systemic inflammation are an indicator of limited gene 
expression of cytokines in the brain to counteract IL-1 
bioactivity. 
Rheumatoid arthritis, osteoarthritis 
Prognosis 
IL-1 Beta activity has been linked to a TNF-
alpha/cAMP pathway involved in rheumatoid arthritis. 
Synergistic up-regulation in IL-1 beta synthesis by 
TNF-alpha/cAMP has been proposed to play a role in 
the permanent IL-1 beta levels continuously present in 
chronically inflamed joints. IL-1 beta production is 
regulated by the TNF-alpha/cAMP pathway at the 
transcription level requiring a cAMP response element 
located between -2762 and -2755 bp in the upstream 
regulatory sequence of IL-1 beta. 
Periodontal disease 
Prognosis 
The severity of periodontal disease could be evaluated 
through IL-1 beta activity. Liu et al. (1996) identified 
IL-1beta as playing a pivotal role in the pathogenic 
mechanism of periodontal tissue destruction. According 
to the authors, clinical parameters such as gingival 
index (GI), probing depth (PD) and GCF flow were 
significantly correlated with gingival crevicular fluid 
(GCF) and tissue IL-1beta activity. Moreover, the 
degree of inflammation within periodontal disease 
tissue could be measured IL-1beta activity in GCF or 
diseased tissues based on the classification of clinical 
parameters. 
An additional study corroborated above mentioned 
finding of  IL-1 beta levels as a biomarker of  
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periodontal disease. Elevated salivary levels of MMP-8 
or IL-1beta or both combined, were found to 
significantly increase the risk of periodontal disease. 
Salivary levels of MMP-8 and IL-1beta could serve as 
biomarkers of periodontitis. 
Erosive hand osteoarthritis (OA) 
Note 
There is a significant association between the genomic 
region containing the IL1B 5810 SNP and erosive hand 
OA in a group of US Caucasoid population (Stern et 
al., 2003). The IL1B 5810 AA genotype was 
significantly associated with the erosive hand OA 
subgroup (relative risk 3.8, p=0.007). The same 
genotype association was found significant between 
erosive and non-erosive hand OA subjects (relative risk 
4.01, p=0.008). The IL1B 5810A allele occurs most 
frequently on haplotypes with the SNP alleles IL1B 
1423C, IL1B 1903T, IL1B 5887C, and IL1A (-)889C. 
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